Mills Kenneth T.'s Form 4 filing
REGENXBIO Inc.RGNX · filed Sep 15, 2021
- Accession no.
- 0001562180-21-005947
- Filed
- Sep 15, 2021
- Trade date
- Sep 13-14, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.70M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mills Kenneth T.CIK 0001652824 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2021 | Common Stock | MOption exerciseAcquired | +3,000 | $3.76 | +$11,280 | 283,984 | Direct | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −3,000 | $40.02 | −$120,060 | 280,984 | Direct | |
| Sep 14, 2021 | Common Stock | MOption exerciseAcquired | +33,146 | $3.76 | +$124,628.96 | 314,130 | Direct | |
| Sep 14, 2021 | Common Stock | MOption exerciseAcquired | +1,854 | $0.85 | +$1,575.9 | 315,984 | Direct | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −35,000 | $45.11F2 | −$1,578,850 | 280,984 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2021 | Common Stock | MOption exerciseDisposed | −3,000 | $0.00 | $0 | 266,000 | Direct | |
| Sep 14, 2021 | Common Stock | MOption exerciseDisposed | −33,146 | $0.00 | $0 | 232,854 | Direct | |
| Sep 14, 2021 | Common Stock | MOption exerciseDisposed | −1,854 | $0.00 | $0 | 37,816 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $45.00 to $45.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.